# FanZhuo Capital

> FanZhuo Capital is a VC fund in Beijing Shi backing Manufacturing, Medical and Chemical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing Shi, China
- Total investments: 5
- Last investment: Feb 2026
- Lead investor: 40%
- Last updated: Aug 2026
- Website: https://www.fzcap.cn/

FanZhuo Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 2 | 40% |
| Medical | 1 | 20% |
| Chemical | 1 | 20% |
| Software | 1 | 20% |
| A/B Testing | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Venture - Series Unknown | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Coyin Bio | Coyin Bio is a forward-looking technology innovation company dedicated to the research, development, and large-scale manufacturing of high-quality pharmaceutical products. By integrating advanced scientific expertise, cutting-edge production technologies, and stringent quality control standards, the company delivers safe, effective, and reliablemedicines that address evolving healthcare needs. |  | Series A | Feb 26, 2026 |  |
| Microbridge Testing | Microbridge Testing is a professional provider of industrial automated test equipment and system solutions. It produces flat panel display test equipment and semiconductor test equipment. |  | Series A | Aug 21, 2025 |  |
| Nanke Hegu | Nanke Hegu is a hydrogen production catalyst product developer, with an emphasis on the research and development of essential technologies for high-efficiency ruthenium-based hydrogen production catalysts, as well as industrialization. | $2.7M | Venture - Series Unknown | Dec 20, 2024 |  |
| Orienspace | Orienspace aims to expand development space, allow people to enjoy space civilisation, and supplement global space launch capabilities. | $59.9M | Series A | May 20, 2022 |  |
| Taimei Technology | Taimei Technology provides a cloud platform for clinical research collaboration. It is dedicated to propelling biopharmaceutical industry development through technology with a focus in the field of clinical research and pharmacovigilance. Taimei Technology cloud platform was designed for clinical research collaboration between sponsors, sites,CROs, patients, regulatory agencies and third-party providers. Its platform offers 6 technology-enabled solutions encompassing data management, project management, electronic regulatory submission, central medical imaging, pharmacovigilance, and drug logistics. Its clients include pharmaceutical enterprises, CRO and research institutes. The company was founded in 2013 and is headquartered in Jiaxing, Zhejiang, China. | $176.2M | Venture - Series Unknown | Sep 28, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [CMBC International Holdings](https://shizune.co/investors/profile/cmbc-international-holdings) — VC Fund, 1 deal together
- [Cowin Venture](https://shizune.co/investors/profile/cowin-venture) — VC Fund, 1 deal together
- [Future Ventures](https://shizune.co/investors/profile/future-ventures) — VC Fund, 1 deal together
- [GL Ventures](https://shizune.co/investors/profile/gl-ventures) — VC Fund, 1 deal together
- [GL Ventures LLC](https://shizune.co/investors/profile/gl-ventures-llc) — VC Fund, 1 deal together
- [Hike Capital](https://shizune.co/investors/profile/hike-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does FanZhuo Capital invest in?

FanZhuo Capital invests primarily in Manufacturing, Medical and Chemical startups, most often at Series A and Venture - Series Unknown stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did FanZhuo Capital last invest?

The most recent investment recorded for FanZhuo Capital closed in Feb 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co